2 months Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance MarketBeat
Biogen (NASDAQ:BIIB) updated its FY 2024 earnings guidance. The company provided EPS guidance of 16.100-16.600 for the period, compared to the consensus estimate of 16.190.
Biogen (BIIB) · Earnings · Nasdaq 100
X